loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 208624 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    AbbVie Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ABBVIE (1)

    filter

    01 TABLET, EXTENDED RELEASE;ORAL (1)

    filter

    01 DISCN (1)

    filter

    01 VIEKIRA XR (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED R...
    EQ 200MG BASE;8.33...
    2016-07-22
    208624
    VIEKIRA XR
    DISCN
    Yes
    Abbvie Company Banner

    Swiss Biotech Day

    Not Confirmed

    envelop Contact Supplier

    Looking for FDA Orange Book APPLICATION 208624

    Looking for FDA Orange Book APPLICATION 208624 1

    19

    AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR, with a corresponding application number 208624.

    Regulatory Information DISCN

    With a dosage strength EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 2016-07-22

    Post Enquiry
    POST ENQUIRY